Close Menu

You may find more results for this query on our sister sites: 360Dx and Precision Oncology News.

Home » Business, Policy & Funding » Business News » Precision Cancer Software Startup BostonGene Lands $50M in Series A Round

Precision Cancer Software Startup BostonGene Lands $50M in Series A Round

Apr 25, 2019
|
staff reporter

NEW YORK (GenomeWeb) – Biomedical software startup BostonGene today announced that it has received a $50 million Series A investment from Japanese software giant NEC.

To read the full story....

...and receive Daily News bulletins.

Already have a GenomeWeb or 360Dx account?
Login Now.

Don't have a GenomeWeb or 360Dx account?
Register for Free.

The Scan

Shift to New Variant Work

Imperial College London researchers are shifting away from testing a COVID-19 vaccine to focus on combating newly emerging SARS-CoV-2 variants, the Independent says.

Victim Identified with Genetic Genealogy

According to the Associated Press, genetic genealogy has helped law enforcement officials identify an unknown victim of the Green River Killer.

PNAS Papers on Chemotherapy-Induced Cardiac Injury Target, Viral Insertions, SMRT Methylation Profiling

In PNAS this week: target to reduce chemotherapy-induced cardiac injury, tool finds ancient endogenous RNA viruses, and more.

Should Also Work

Moderna reports its vaccine is effective against new SARS-CoV-2 strains, though it is also developing a booster, according to the New York Times.

What's Popular?

In Business News

  1. Thermo Fisher Scientific, SPT Labtech to Comarket Sequencing Library Prep Products

  2. Split Biosciences Rebrands as Parse Biosciences, Raises $7M in Series A Financing

  3. Ambry Genetics Gets FDA Emergency Use Authorization for Coronavirus Test

  4. Genomind Receives Medicare Coverage for Pharmacogenetics Test

  5. NRGene Completes $30.6M IPO

Sponsorships

Privacy Policy.  Terms & Conditions.  .  Copyright © 2021 GenomeWeb, a business unit of Crain Communications.  All Rights Reserved.